2009-11-16 05:09:23 -
BELLUS Health Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com
www.companiesandmarkets.com/Summary-Company-Profile/bellus-healt ..
BELLUS Health Inc. and its subsidiaries, formerly known as Neurochem Inc. (BELLUS Health) is a global health company focused on the development and commercialization of products to provide health solutions to address critical unmet needs. In September 2008, the Company launched its first product, VIVIMIND (also known as trmiprostate and homotaurine), in Canada and globally on the Internet. On July 17, 2008, the Company completed the acquisition of Innodia Inc. (Innodia), a private company engaged in developing compounds for the treatment of diabetes, obesity and related metabolic conditions and diseases. The product candidates of the Company include eprodisate (KIACTA), NC-503 and prodrug of tramiprostate.
BELLUS Health Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
BELLUS Health (BELLUS) is a global
health company engaged in developing and commercializing of products to provide innovative health solutions to address critical unmet needs. The company targets disorders for which there are currently no known cures and limited therapies. The company´s investigational product candidates are targeted at the treatment of Amyloid A amyloidosis, Type II diabetes and certain features of metabolic syndrome, and Alzheimers disease. Bellus Health is headquartered at Laval, Canada.
The BELLUS Health Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
